How effective is Spiriva for Bronchiectasis? (a real world drug study)
Summary:
Overall ratings: 3.2/5 Long term ratings: 3/5
This is a phase IV clinical study of how effective Spiriva (tiotropium bromide monohydrate) is for Bronchiectasis and for what kind of people. The study is created by eHealthMe from 5 Spiriva users and is updated continuously.
What is Spiriva?
Spiriva has active ingredients of tiotropium bromide monohydrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 156,666 Spiriva users. Check the latest studies of Spiriva.
What is Bronchiectasis?
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection) is found to be associated with 804 drugs and 855 conditions by eHealthMe. Check the latest studies of Bronchiectasis.
5 people are studied for taking Spiriva in Bronchiectasis
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Spiriva effectiveness for Bronchiectasis (number of people):
Overall:
- not at all: 0
- somewhat: 1
- moderate: 2
- high: 2
- very high: 0
Long Term:
- not at all: 0
- somewhat: 1
- moderate: 1
- high: 1
- very high: 0
Gender of people who take Spiriva for Bronchiectasis *:
- female: 80 %
- male: 20 %
Age of people who take Spiriva for Bronchiectasis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 20 %
- 50-59: 40 %
- 60+: 40 %
Who find Spiriva more effective for Bronchiectasis?
Gender of people who take Spiriva for Bronchiectasis *:
- female: 50 %
- male: 50 %
Age of people who take Spiriva for Bronchiectasis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
* Approximation only. Some reports may have incomplete information.
Do you take Spiriva?
- You can start a phase IV clinical trial to monitor Spiriva safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Lee JK, Lee J, Park SS, Heo EY, Park YS, Lee CH, Lee SM, Yoon HI, Yim JJ, Yoo CG, Chung HS, "Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis", The International Journal of Tuberculosis and Lung Disease, 2014 Mar .
- Lee JK, Lee J, Park SS, Heo EY, Park YS, Lee CH, Lee SM, Yoon HI, Yim JJ, Yoo CG, Chung HS, "Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis", The International Journal of Tuberculosis and Lung Disease, 2014 Mar .
Related studies
Alternative drugs to, pros and cons of:
- Spiriva (156,666 reports)
Treatments, associated drugs and conditions:
- Bronchiectasis (12,460 reports)
How the study uses the data?
The study is based on tiotropium bromide monohydrate (the active ingredients of Spiriva) and Spiriva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Elavil and Skin Blushing/Flushing for Women aged 50-59 - 10 seconds ago
- Elavil and Red Face for Women aged 50-59 - 10 seconds ago
- Elavil and Blushing for Women aged 50-59 - 10 seconds ago
- Elavil and Flushing for Women aged 50-59 - 11 seconds ago
- Could Ventavis cause Fainting? - 16 seconds ago
- Drug interactions of Advair Hfa and Tysabri - 31 seconds ago
- Lioresal and Loss Of Consciousness for Women aged 60+ - 33 seconds ago
- Could Atelvia cause Insomnia? - 36 seconds ago
- Could Darvocet cause Hypothermia? - 41 seconds ago
- Ranitidine and Lupus-Like Syndrome for Men aged 60+ - 47 seconds ago